Applied Molecular Transport Stock Price To Earnings To Growth
Applied Molecular Transport fundamentals help investors to digest information that contributes to Applied Molecular's financial success or failures. It also enables traders to predict the movement of Applied Stock. The fundamental analysis module provides a way to measure Applied Molecular's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Applied Molecular stock.
Applied |
Applied Molecular Transport Company Price To Earnings To Growth Analysis
Applied Molecular's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Applied Molecular Price To Earnings To Growth | (0.01) X |
Most of Applied Molecular's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Applied Molecular Transport is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, Applied Molecular Transport has a Price To Earnings To Growth of -0.01 times. This is 101.41% lower than that of the Biotechnology sector and 100.32% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.2% higher than that of the company.
Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
All Next | Launch Module |
Applied Fundamentals
Return On Equity | -1.58 | |||
Return On Asset | -0.51 | |||
Current Valuation | (5.88 M) | |||
Shares Outstanding | 41.85 M | |||
Shares Owned By Insiders | 21.35 % | |||
Shares Owned By Institutions | 37.20 % | |||
Number Of Shares Shorted | 292.87 K | |||
Price To Book | 0.70 X | |||
Gross Profit | (42.08 M) | |||
EBITDA | (127.22 M) | |||
Net Income | (126.33 M) | |||
Cash And Equivalents | 95.83 M | |||
Cash Per Share | 2.46 X | |||
Total Debt | 36.12 M | |||
Debt To Equity | 0.38 % | |||
Current Ratio | 6.25 X | |||
Book Value Per Share | 0.40 X | |||
Cash Flow From Operations | (93.9 M) | |||
Short Ratio | 0.96 X | |||
Earnings Per Share | (1.89) X | |||
Price To Earnings To Growth | (0.01) X | |||
Target Price | 1.0 | |||
Number Of Employees | 13 | |||
Beta | 2.29 | |||
Market Capitalization | 11.01 M | |||
Total Asset | 107.45 M | |||
Retained Earnings | (365.97 M) | |||
Working Capital | 48.93 M | |||
Z Score | -7.95 | |||
Net Asset | 107.45 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Applied Stock
If you are still planning to invest in Applied Molecular check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Applied Molecular's history and understand the potential risks before investing.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |